Detection  	Detection  	 NNP	O
of  	of  	 IN	O
treatment-resistant  	treatment-resistant  	 JJ	B-NP
infectious  	infectious  	 JJ	I-NP
HIV  	HIV  	 NN	I-NP
after  	after  	 IN	O
genome-directed  	genome-directed  	 FW	B-NP
antiviral  	antiviral  	 FW	I-NP
endonuclease  	endonuclease  	 FW	I-NP
therapy  	therapy  	 FW	I-NP
Incurable  	Incurable  	 FW	I-NP
chronic  	chronic  	 FW	I-NP
viral  	viral  	 FW	I-NP
infections  	infections  	 NNS	I-NP
are  	are  	 VBP	O
a  	a  	 DT	O
major  	major  	 JJ	O
cause  	cause  	 NN	O
of  	of  	 IN	O
morbidity  	morbidity  	 NN	O
and  	and  	 CC	O
mortality  	mortality  	 NN	O
worldwide 	worldwide 	 NN	O
.  	.  	 .	O
One  	One  	 CD	O
potential  	potential  	 JJ	B-NP
approach  	approach  	 NN	I-NP
to  	to  	 TO	O
cure  	cure  	 VB	O
persistent  	persistent  	 JJ	O
viral  	viral  	 JJ	B-NP
infections  	infections  	 NN	I-NP
is  	is  	 VBZ	O
via  	via  	 IN	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
targeted  	targeted  	 JJ	O
endonucleases 	endonucleases 	 NN	B-NP
.  	.  	 .	O
Nevertheless 	Nevertheless 	 RB	O
,  	,  	 ,	O
a  	a  	 DT	O
potential  	potential  	 JJ	B-NP
concern  	concern  	 NN	I-NP
for  	for  	 IN	I-NP
endonuclease-based  	endonuclease-based  	 JJ	I-NP
antiviral  	antiviral  	 JJ	I-NP
therapies  	therapies  	 NN	I-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
emergence  	emergence  	 NN	O
of  	of  	 IN	O
treatment  	treatment  	 NN	B-NP
resistance 	resistance 	 NN	I-NP
.  	.  	 .	O
Here  	Here  	 RB	O
we  	we  	 PRP	O
detect  	detect  	 VBP	O
for  	for  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
time  	time  	 NN	O
an  	an  	 DT	O
endonuclease-resistant  	endonuclease-resistant  	 JJ	B-NP
infectious  	infectious  	 JJ	I-NP
virus  	virus  	 NN	I-NP
that  	that  	 WDT	O
is  	is  	 VBZ	O
found  	found  	 VBN	O
with  	with  	 IN	O
high  	high  	 JJ	O
frequency  	frequency  	 NN	O
after  	after  	 IN	O
antiviral  	antiviral  	 JJ	B-NP
endonuclease  	endonuclease  	 JJ	I-NP
therapy 	therapy 	 NN	I-NP
.  	.  	 .	O
While  	While  	 IN	O
testing  	testing  	 VBG	O
the  	the  	 DT	O
activity  	activity  	 NN	O
of  	of  	 IN	O
HIV  	HIV  	 NNP	B-NP
pol-specific  	pol-specific  	 FW	I-NP
zinc  	zinc  	 FW	I-NP
finger  	finger  	 FW	I-NP
nucleases  	nucleases  	 FW	I-NP
( 	( 	 -LRB-	O
ZFNs 	ZFNs 	 NNP	B-NP
)  	)  	 -RRB-	O
alone  	alone  	 RB	O
or  	or  	 CC	O
in  	in  	 IN	O
combination  	combination  	 NN	O
with  	with  	 IN	O
three  	three  	 CD	B-NP
prime  	prime  	 JJ	I-NP
repair  	repair  	 NN	I-NP
exonuclease  	exonuclease  	 VBD	I-NP
2  	2  	 CD	I-NP
( 	( 	 -LRB-	O
Trex2 	Trex2 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
we  	we  	 PRP	O
identified  	identified  	 VBD	O
a  	a  	 DT	O
treatment-resistant  	treatment-resistant  	 JJ	O
and  	and  	 CC	O
infectious  	infectious  	 JJ	B-NP
mutant  	mutant  	 JJ	I-NP
virus  	virus  	 NN	I-NP
that  	that  	 WDT	O
was  	was  	 VBD	O
derived  	derived  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
ZFN-mediated  	ZFN-mediated  	 JJ	B-NP
disruption  	disruption  	 NN	I-NP
of  	of  	 IN	I-NP
reverse  	reverse  	 JJ	I-NP
transcriptase  	transcriptase  	 NNS	I-NP
( 	( 	 -LRB-	O
RT 	RT 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Although  	Although  	 IN	O
gene  	gene  	 NN	B-NP
disruption  	disruption  	 NN	I-NP
of  	of  	 IN	I-NP
HIV  	HIV  	 NNP	I-NP
protease 	protease 	 NN	I-NP
,  	,  	 ,	O
RT  	RT  	 NNP	B-NP
and  	and  	 CC	O
integrase  	integrase  	 NNS	B-NP
could  	could  	 MD	O
inhibit  	inhibit  	 VB	O
viral  	viral  	 JJ	B-NP
replication 	replication 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
chance  	chance  	 NN	O
single  	single  	 JJ	O
amino  	amino  	 JJ	O
acid  	acid  	 NN	B-NP
insertion  	insertion  	 NN	I-NP
within  	within  	 IN	O
the  	the  	 DT	O
thumb  	thumb  	 NN	B-NP
domain  	domain  	 NN	I-NP
of  	of  	 IN	I-NP
RT  	RT  	 NNP	I-NP
produced  	produced  	 VBD	O
a  	a  	 DT	O
virus  	virus  	 NN	O
that  	that  	 WDT	O
could  	could  	 MD	O
actively  	actively  	 RB	O
replicate 	replicate 	 VB	O
.  	.  	 .	O
The  	The  	 DT	O
endonuclease-resistant  	endonuclease-resistant  	 JJ	B-NP
virus  	virus  	 NN	I-NP
could  	could  	 MD	O
replicate  	replicate  	 VB	O
in  	in  	 IN	O
primary  	primary  	 JJ	B-NP
CD4 	CD4 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
+ 	+ 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
T  	T  	 NN	I-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
remained  	remained  	 VBD	O
susceptible  	susceptible  	 JJ	O
to  	to  	 TO	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
antiretroviral  	antiretroviral  	 FW	B-NP
RT  	RT  	 FW	I-NP
inhibitors 	inhibitors 	 FW	I-NP
.  	.  	 .	O
When  	When  	 WRB	O
secondary  	secondary  	 JJ	B-NP
ZFN-derived  	ZFN-derived  	 JJ	I-NP
mutations  	mutations  	 NNS	I-NP
were  	were  	 VBD	O
introduced  	introduced  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
mutant  	mutant  	 JJ	B-NP
virus 	virus 	 NN	I-NP
's  	's  	 POS	O
RT  	RT  	 NNP	B-NP
or  	or  	 CC	O
integrase  	integrase  	 JJ	B-NP
domains 	domains 	 NN	I-NP
,  	,  	 ,	O
replication  	replication  	 NNS	B-NP
could  	could  	 MD	O
be  	be  	 VB	O
abolished 	abolished 	 VBN	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
observations  	observations  	 NNS	B-NP
suggest  	suggest  	 VBP	O
that  	that  	 DT	O
caution  	caution  	 NN	O
should  	should  	 MD	O
be  	be  	 VB	O
exercised  	exercised  	 VBN	O
during  	during  	 IN	O
endonuclease-based  	endonuclease-based  	 JJ	B-NP
antiviral  	antiviral  	 JJ	I-NP
therapies 	therapies 	 NNS	I-NP
;  	;  	 :	O
however 	however 	 RB	O
,  	,  	 ,	O
combination  	combination  	 NN	B-NP
endonuclease  	endonuclease  	 NN	I-NP
therapies  	therapies  	 NNS	I-NP
may  	may  	 MD	O
prevent  	prevent  	 VB	O
the  	the  	 DT	O
emergence  	emergence  	 NN	O
of  	of  	 IN	O
resistance 	resistance 	 NN	O
.  	.  	 .	O
